Article info

Download PDFPDF

Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

Authors

  1. Correspondence to Dr Pete Humphries; Pete.Humphries{at}tcd.ie
View Full Text

Citation

Kenna PF, Humphries MM, Kiang A, et al
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

Publication history

  • Received March 9, 2020
  • Revised March 30, 2020
  • Accepted April 2, 2020
  • First published May 5, 2020.
Online issue publication 
May 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.